CS logo
small CS logo
Box Hill Hospital

Box Hill, Victoria, Australia
Teaching hospital in Box Hill, Victoria
8 Arnold St, Box Hill VIC 3128
621 Beds

About Box Hill Hospital


Box Hill Hospital is a teaching hospital in Melbourne. It is one of the seven hospitals that are governed within the Eastern Health network which provides health care services across the Eastern metropolitan area of Victoria.
There are 621 beds in Box Hill Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
27
Eli Lilly and Company
12
Gilead Sciences
9
Neuroscience Trials Australia
8
ETOP IBCSG Partners Foundation
6
Hoffmann-La Roche
6
Janssen Research & Development, LLC
6
BeiGene
5
The George Institute
5
Australian and New Zealand Intensive Care Research Centre
4
Boehringer Ingelheim
4
Total Rows: 100

Clinical Trials at Box Hill Hospital


During the past decade, Box Hill Hospital conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 73 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 33 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years9912122222272713131818202015152277441010881111881313101022Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
2000-11-01
2016-08-01
Completed
1,086
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2005-03-01
Completed
623
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
2002-07-01
2016-08-22
Completed
162
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
2003-06-01
2008-07-01
Completed
551
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
2004-04-01
2007-05-01
Completed
5,745

Rows per page:

1–100 of 232

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Box Hill Hospital" #1 sponsor was "Pfizer" with 27 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Neuroscience Trials Australia" with 8 trials sponsored and "ETOP IBCSG Partners Foundation" with 8 trials sponsored. Other sponsors include 165 different institutions and companies that sponsored additional 114 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Box Hill Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 11 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator, "The Florey Institute of Neuroscience and Mental Health" with 5 trials as a collaborator and "Astellas Pharma Inc" with 4 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 149 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 27Pfizer: 27Eli Lilly and Company: 12Eli Lilly and Company: 12Gilead Sciences: 9Gilead Sciences: 9Neuroscience Trials Australia: 8Neuroscience Trials Australia: 8ETOP IBCSG PartnersFoundation: 6ETOP IBCSG PartnersFoundation: 6Hoffmann-La Roche: 6Hoffmann-La Roche: 6Janssen Research &Development, LLC: 6Janssen Research &Development, LLC: 6BeiGene: 5BeiGene: 5The George Institute: 5The George Institute: 5Australian and NewZealand Intensive CareResearch Centre: 4Australian and NewZealand Intensive CareResearch Centre: 4

Created with Highcharts 11.1.0Top CollaboratorsNational Health andMedical ResearchCouncil, Australia: 11National Health andMedical ResearchCouncil, Australia: 11Australian and NewZealand Urogenital andProstate Cancer TrialsGroup: 5Australian and NewZealand Urogenital andProstate Cancer TrialsGroup: 5Breast International Group: 5Breast International Group: 5The Florey Institute ofNeuroscience andMental Health: 5The Florey Institute ofNeuroscience andMental Health: 5Astellas Pharma Inc: 4Astellas Pharma Inc: 4Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 4Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 4Bristol-Myers Squibb: 4Bristol-Myers Squibb: 4Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:4Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:4Merck KGaA,Darmstadt, Germany: 4Merck KGaA,Darmstadt, Germany: 4Merck Sharp & Dohme LLC: 4Merck Sharp & Dohme LLC: 4

Clinical Trials Conditions at Box Hill Hospital


According to Clinical.Site data, the most researched conditions in "Box Hill Hospital" are "Breast Cancer" (11 trials), "Prostate Cancer" (8 trials), "Stroke" (8 trials), "Ulcerative Colitis" (7 trials) and "Alzheimer's Disease" (5 trials). Many other conditions were trialed in "Box Hill Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Box Hill Hospital


Most popular intervention types in "Box Hill Hospital" are "Drug" (202 trials), "Other" (31 trials), "Biological" (20 trials), "Procedure" (9 trials) and "Device" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (67 trials), "Cisplatin" (6 trials), "Enzalutamide" (6 trials), "Paclitaxel" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Box Hill Hospital


The vast majority of trials in "Box Hill Hospital" are 206 trials for "All" genders, 13 trials for "Female" genders and 13 trials for "Male" genders.

Clinical Trials Status at Box Hill Hospital


Currently, there are 102 active trials in "Box Hill Hospital". 1 are not yet recruiting, 52 are recruiting, 46 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 93 completed trials in Box Hill Hospital, undefined suspended trials, and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Box Hill Hospital, 14 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 129Phase 3: 129Phase 2: 73Phase 2: 73Phase 1: 14Phase 1: 14Phase 4: 10Phase 4: 10Not Applicable: 8Not Applicable: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 93Completed: 93Recruiting: 52Recruiting: 52Active, not recruiting: 46Active, not recruiting: 46Terminated: 28Terminated: 28Unknown status: 7Unknown status: 7Enrolling by invitation: 3Enrolling by invitation: 3Available: 1Available: 1Not yet recruiting: 1Not yet recruiting: 1Withdrawn: 1Withdrawn: 1